Novocure
NVCR----
Novocure (NVCR)
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatm...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Novocure Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$27.1748.29%
Forecast & RatingBuy
6analysts
- Strong buy33.33%
- Buy16.67%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 14 minutes ago
NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Sliding
- Market Beat · 3 hours ago
FY2029 EPS Estimates for NovoCure Decreased by HC Wainwright
- rttnews · 4 hours ago
Biotech Stocks At 52-Week Highs - MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVB
- Global Report · 6 hours ago
Niche Market Leaders Execute Buybacks and AI Pivots in Late 2026
- rttnews · 11 hours ago
Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focus
- TradingKey · 13 hours ago
NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery
